Cross-Species Transmission and Evolution of SIV Chimpanzee Progenitor Viruses Toward HIV-1 in Humanized Mice
Related Experiment Video
Updated: Dec 10, 2025

Humanized NOG Mice for Intravaginal HIV Exposure and Treatment of HIV Infection
Published on: January 31, 2020
Kimberly Schmitt1, James Curlin1, Leila Remling-Mulder1
1Department of Microbiology, Immunology, and Pathology, Colorado State University, Fort Collins, CO, United States.
Abstract:
The genetic evolution of HIV-1 from its progenitor virus SIV following cross-species transmission is not well understood. Here we simulated the SIVcpz initial transmission to humans using humanized mice and followed the viral evolution during serial passages lasting more than a year. All three SIVcpz progenitor viruses used, namely LB715 and MB897 (group M) as well as EK505 (group N) readily infected hu-mice resulting in chronic viremia. Viral loads increased progressively to higher set-points and the CD4+ T cell decline became more pronounced by the end of the second serial passage indicating viral adaptation and increased pathogenicity. Viral genomes sequenced at different time points revealed many non-synonymous variants not previously reported that occurred throughout the viral genome, including the gag, pol, env, and nef genes. These results shed light on the potential changes that the SIVcpz genome had undergone during the initial stages of human infection and subsequent spread.
Insights
Simulating simian immunodeficiency virus (SIVcpz) transmission to humans in mice revealed viral adaptation and increased pathogenicity. Genetic analysis showed novel variants in key genes, offering insights into early human immunodeficiency virus type 1 (HIV-1) evolution.
Area of Science:
- Virology
- Genetics
- Immunology
Background:
- The cross-species transmission of simian immunodeficiency virus (SIVcpz) to humans, leading to the emergence of human immunodeficiency virus type 1 (HIV-1), is not fully understood.
- Understanding the initial genetic changes and adaptation of SIVcpz during human infection is crucial for comprehending HIV-1 origins and evolution.
Purpose of the Study:
- To simulate the initial transmission of SIVcpz to humans using a humanized mouse model.
- To investigate the viral evolution, pathogenicity, and genetic alterations of SIVcpz during serial passages in vivo.
- To identify potential genomic changes in SIVcpz that may have occurred during the early stages of human infection.
Main Methods:
- Serial passage of three SIVcpz strains (LB715, MB897, EK505) in humanized mice.
- Monitoring of viral loads and CD4+ T cell counts throughout the passages.
- Sequencing of viral genomes at different time points to identify genetic variants.
Main Results:
- SIVcpz strains readily infected humanized mice, establishing chronic viremia.
- Viral loads increased to higher set-points, and CD4+ T cell decline became more pronounced after the second passage, indicating adaptation and increased pathogenicity.
- Sequencing revealed numerous novel non-synonymous variants across the viral genome, including gag, pol, env, and nef genes.
Conclusions:
- Humanized mice effectively model SIVcpz adaptation and increased pathogenicity following cross-species transmission.
- The study identified significant genetic changes in SIVcpz during early in vivo evolution, providing insights into potential HIV-1 progenitor alterations.
- These findings contribute to understanding the genomic landscape of SIVcpz during the initial phase of human infection and subsequent spread.
Related Concept Videos
Synteny and Evolution
Around 80 million years ago, the human and mice lineages diverged from the common ancestor. During the course of evolution, the ancestral...
Viral Mutations

